Qualigen Therapeutics (QLGN), a Nasdaq-listed company, has completed its crypto custody setup, including USD cash settlement and bank accounts, over the past two weeks. The company is set to begin purchasing strategic assets this week, focusing on top cryptocurrencies like BNB, ETH, and SOL. This move follows a $41 million investment by FF and a $4 million contribution from Jia Yueting. QLGN plans to rebrand as CXC 10.